FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013896089> ?p ?o ?g. }

• W2013896089 endingPage "593" @default.
• W2013896089 startingPage "593" @default.
• W2013896089 abstract "Edoxaban is an oral, once-daily, selective, direct factor Xa inhibitor approved in Japan for the prevention of venous thromboembolism following major orthopedic surgery. Currently, edoxaban is in Phase III clinical development for the prevention of stroke and systemic embolic events in patients with atrial fibrillation, and for the treatment and prevention of recurrences of venous thromboembolism. This report describes the adverse drug reactions (ADRs) spontaneously reported during early postmarketing phase vigilance from the time of its commercial launch in Japan.All spontaneously reported ADRs following edoxaban use received by Daiichi Sankyo during early postmarketing phase vigilance from July 19, 2011, to January 18, 2012, were entered into the safety database and included in this review. Approximately 20,000 patients were estimated to have been treated with edoxaban.The mean age of patients was 74.2 years, their mean weight was 59.4 kg, and approximately 70% were female. A total of 67 ADRs were reported in 56 patients, of which the majority included bleeding events (51 ADRs in 42 patients). Of these, 15 ADRs (in 14 patients) were serious, including cerebral hemorrhage (n = 1), gastric hemorrhage (n = 2; gastric hemorrhage [n = 1] and gastric ulcer hemorrhage [n = 1]), and surgical-site hemorrhage (n = 12; hemorrhage [n = 6], subcutaneous hemorrhage [n = 3], wound hemorrhage [n = 2], and wound hematoma [n = 1]). Most ADRs occurred within the first week of treatment and there were no fatalities. Nonserious ADRs associated with bleeding that occurred in >1 patient included subcutaneous hemorrhage (n = 9), wound hemorrhage (n = 5), postprocedural hematoma (n = 4), anemia (n = 4), and hemarthrosis (n = 3). Other nonserious ADRs not associated with bleeding and occurring in >1 patient included abnormal hepatic function (n = 4) and diarrhea (n = 2).Safety data from the first 6 months of postmarketing experience with edoxaban did not identify any unforeseen safety signals, consistent with the known safety profile of edoxaban." @default.
• W2013896089 created "2016-06-24" @default.
• W2013896089 creator A5001134057 @default.
• W2013896089 creator A5014345949 @default.
• W2013896089 creator A5018699372 @default.
• W2013896089 creator A5021538982 @default.
• W2013896089 creator A5022683863 @default.
• W2013896089 date "2013-10-01" @default.
• W2013896089 modified "2023-09-23" @default.
• W2013896089 title "Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery" @default.
• W2013896089 cites W1528007237 @default.
• W2013896089 cites W1866866972 @default.
• W2013896089 cites W1965320794 @default.
• W2013896089 cites W1974709342 @default.
• W2013896089 cites W1986579965 @default.
• W2013896089 cites W2030368027 @default.
• W2013896089 cites W2039761330 @default.
• W2013896089 cites W2077084168 @default.
• W2013896089 cites W2078568237 @default.
• W2013896089 cites W2107205214 @default.
• W2013896089 cites W2110992040 @default.
• W2013896089 cites W2131099415 @default.
• W2013896089 cites W2159346746 @default.
• W2013896089 cites W2161735825 @default.
• W2013896089 cites W2167407993 @default.
• W2013896089 cites W2573241941 @default.
• W2013896089 cites W2587603227 @default.
• W2013896089 cites W6072419 @default.
• W2013896089 cites W2124120026 @default.
• W2013896089 cites W2183452488 @default.
• W2013896089 doi "https://doi.org/10.2147/vhrm.s51244" @default.
• W2013896089 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3794866" @default.
• W2013896089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24124376" @default.
• W2013896089 hasPublicationYear "2013" @default.
• W2013896089 type Work @default.
• W2013896089 sameAs 2013896089 @default.
• W2013896089 citedByCount "19" @default.
• W2013896089 countsByYear W20138960892014 @default.
• W2013896089 countsByYear W20138960892015 @default.
• W2013896089 countsByYear W20138960892016 @default.
• W2013896089 countsByYear W20138960892017 @default.
• W2013896089 countsByYear W20138960892018 @default.
• W2013896089 countsByYear W20138960892020 @default.
• W2013896089 crossrefType "journal-article" @default.
• W2013896089 hasAuthorship W2013896089A5001134057 @default.
• W2013896089 hasAuthorship W2013896089A5014345949 @default.
• W2013896089 hasAuthorship W2013896089A5018699372 @default.
• W2013896089 hasAuthorship W2013896089A5021538982 @default.
• W2013896089 hasAuthorship W2013896089A5022683863 @default.
• W2013896089 hasBestOaLocation W20138960891 @default.
• W2013896089 hasConcept C126322002 @default.
• W2013896089 hasConcept C141071460 @default.
• W2013896089 hasConcept C197636746 @default.
• W2013896089 hasConcept C197934379 @default.
• W2013896089 hasConcept C2776301958 @default.
• W2013896089 hasConcept C2778661090 @default.
• W2013896089 hasConcept C2779161974 @default.
• W2013896089 hasConcept C2780035454 @default.
• W2013896089 hasConcept C2780290652 @default.
• W2013896089 hasConcept C2780542314 @default.
• W2013896089 hasConcept C2780868729 @default.
• W2013896089 hasConcept C2991741193 @default.
• W2013896089 hasConcept C42219234 @default.
• W2013896089 hasConcept C68312169 @default.
• W2013896089 hasConcept C71924100 @default.
• W2013896089 hasConcept C98274493 @default.
• W2013896089 hasConceptScore W2013896089C126322002 @default.
• W2013896089 hasConceptScore W2013896089C141071460 @default.
• W2013896089 hasConceptScore W2013896089C197636746 @default.
• W2013896089 hasConceptScore W2013896089C197934379 @default.
• W2013896089 hasConceptScore W2013896089C2776301958 @default.
• W2013896089 hasConceptScore W2013896089C2778661090 @default.
• W2013896089 hasConceptScore W2013896089C2779161974 @default.
• W2013896089 hasConceptScore W2013896089C2780035454 @default.
• W2013896089 hasConceptScore W2013896089C2780290652 @default.
• W2013896089 hasConceptScore W2013896089C2780542314 @default.
• W2013896089 hasConceptScore W2013896089C2780868729 @default.
• W2013896089 hasConceptScore W2013896089C2991741193 @default.
• W2013896089 hasConceptScore W2013896089C42219234 @default.
• W2013896089 hasConceptScore W2013896089C68312169 @default.
• W2013896089 hasConceptScore W2013896089C71924100 @default.
• W2013896089 hasConceptScore W2013896089C98274493 @default.
• W2013896089 hasLocation W20138960891 @default.
• W2013896089 hasLocation W20138960892 @default.
• W2013896089 hasLocation W20138960893 @default.
• W2013896089 hasLocation W20138960894 @default.
• W2013896089 hasLocation W20138960895 @default.
• W2013896089 hasOpenAccess W2013896089 @default.
• W2013896089 hasPrimaryLocation W20138960891 @default.
• W2013896089 hasRelatedWork W2088788340 @default.
• W2013896089 hasRelatedWork W2255616178 @default.
• W2013896089 hasRelatedWork W2343674022 @default.
• W2013896089 hasRelatedWork W2588405059 @default.
• W2013896089 hasRelatedWork W2588625607 @default.
• W2013896089 hasRelatedWork W2760328188 @default.
• W2013896089 hasRelatedWork W3004673954 @default.
• W2013896089 hasRelatedWork W3013012148 @default.
• W2013896089 hasRelatedWork W3132289493 @default.

• next